influenza vaccine surface antigen inactivated prepared in eggs

**Agrippal** is an egg-derived, inactivated trivalent influenza surface-antigen subunit vaccine originally developed by Novartis Vaccines. It was the conventional embryonated-hen-egg comparator in Novartis study V58P4, which evaluated it against the MDCK cell culture-derived vaccine Optaflu. The vaccine is intended for active immunization against seasonal influenza A and B viruses represented by the annually selected vaccine strains. ([has-sante.fr](https://www.has-sante.fr/upload/docs/application/pdf/2013-11/optaflu_ct_12664.pdf))

Brand names

AgrifluAgrippalAgrippal S1BegripalChirofluViraflu

Other names

eTIVegg-derived trivalent influenza vaccineegg-derived trivalent subunit influenza vaccinetrivalent subunit influenza vaccine produced in embryonated hen eggs